Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.

Educational intervention, overprescription reduce opioid use after pelvic floor surgery

15 May 2019
The more painful the surgery, the more likely addiction is, according to a report by the research firm QuintilesIMS Institute for Healthcare Informatics

Overprescription of opioids after pelvic floor surgery and a provider education intervention have led to a substantial decrease in opioid prescribing without changing patient satisfaction with pain control, a recent study has found.

In total, 122 patients were prescribed 149 percent more mean morphine mg equivalents than were actually used for sacral neuromodulation, 165 percent more for mid urethral sling and 136 percent more for prolapse repair.

A significant reduction in morphine mg equivalents prescribed for all three surgeries was observed in 78 patients (p<0.001) after the educational intervention. In addition, the following factors were found to be associated with increased opioid use: diabetes (p=0.001), a chronic pain condition (p=0.017) and rectocele repair (p=0.001).

This retrospective review explored prescribing patterns and opioid use in patients who underwent three pelvic floor surgeries (ie, sacral neuromodulation, prolapse repair and mid urethral sling) from June 2016 to May 2017 before and after an educational intervention to reduce opioid prescriptions.

The authors conducted a telephone survey to quantify opioid use after surgery and satisfaction with pain control. They established prescribing recommendations based on these results and performed an educational intervention for clinicians. This was followed by an assessment of changes in opioid prescription and use during the 6 months following the intervention. To identify factors associated with variability in opioid use, a multiple regression model was used.

“The opioid problem has reached epidemic proportions and the prescription of opioids after surgery can lead to chronic use,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.